TY - JOUR
T1 - The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients
AU - Vanassche, Thomas
AU - Engelen, Matthias M
AU - Orlando, Christelle
AU - Vandenbosch, Kristel
AU - Gadisseur, Alain
AU - Hermans, Cedric
AU - Jochmans, Kristin
AU - Minon, Jean-Marc
AU - Motte, Serge
AU - Peperstraete, Harlinde
AU - Péters, Pierre
AU - Sprynger, Muriel
AU - Lancellotti, Patrizio
AU - Dehaene, Isabelle
AU - Emonts, Patrick
AU - Vandenbriele, Christophe
AU - Verhamme, Peter
AU - Oury, Cecile
N1 - Publisher Copyright:
© Belgian Society of Internal Medicine and Royal Belgian Society of Laboratory Medicine (2023).
PY - 2023/12
Y1 - 2023/12
N2 - COVID-19 is associated with an increased risk for thrombotic complications. The trials investigating the optimal thromboprophylactic dose are performed in challenging times and seemingly produce conflicting evidence. The burdensome circumstances, divergent endpoints, and different analytical approaches hamper comparison and extrapolation of available evidence. Most importantly, clinicians should provide thromboprophylaxis in hospitalized COVID-19 patients while (re)assessing bleeding and thrombotic risk frequently. The COVID-19 Thromboprophylaxis Working Group of the BSTH updated its guidance document. It aims to summarize the available evidence critically and to guide clinicians in providing the best possible thromboprophylaxis.
AB - COVID-19 is associated with an increased risk for thrombotic complications. The trials investigating the optimal thromboprophylactic dose are performed in challenging times and seemingly produce conflicting evidence. The burdensome circumstances, divergent endpoints, and different analytical approaches hamper comparison and extrapolation of available evidence. Most importantly, clinicians should provide thromboprophylaxis in hospitalized COVID-19 patients while (re)assessing bleeding and thrombotic risk frequently. The COVID-19 Thromboprophylaxis Working Group of the BSTH updated its guidance document. It aims to summarize the available evidence critically and to guide clinicians in providing the best possible thromboprophylaxis.
KW - COVID-19
KW - Practice guideline
KW - Anticoagulants
KW - thrombosis
UR - http://www.scopus.com/inward/record.url?scp=85166952953&partnerID=8YFLogxK
U2 - 10.1080/17843286.2023.2241692
DO - 10.1080/17843286.2023.2241692
M3 - Article
C2 - 37548503
VL - 78
SP - 497
EP - 508
JO - Acta Clinica Belgica
JF - Acta Clinica Belgica
SN - 1784-3286
IS - 6
ER -